Clinical Trial Detail

NCT ID NCT01961115
Title INCB024360 and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Fred Hutchinson Cancer Research Center
Indications

melanoma

Therapies

Epacadostat

MELITAC 12.1 Peptide Vaccine

Age Groups: adult

No variant requirements are available.